| Bio-Link News |
|
24/05/2014 - Deal facilitated between a specialty European biopharmaceutical company and the Lions Eye Institute…more 12/05/2014 – Engagement by LiPlasome Pharma to partner LiPlaCis®, a phase I/II clinical candidate for cancer…more 07/11/2013 – Deal facilitated between Centenary Institute and Mirrx Therapeutics …more |
| Client News |
|
16/06/2014 – Professor Roger Reddel, Director of the Childrens Medical Research Institute and Head of the CMRI Cancer Research Unit, recently discussed the role of telomere biology in disease as part of a webinar hosted by Science magazine. 26/05/2014 – LiPlasome Pharma is presenting at ASCO 2014. Meet senior management at the Medical Prognosis Institute Booth #5127. Please see abstract #131616. 06/08/2013 – CMRI has been awarded a CA Skills and Knowledge grant to engage Bio-Link to commercialise the Ring Stabilizer Program for chronic kidney disease …more |
| Industry News |
|
Mon, Jul 21, 2014
Source: FierceBiotech |
| Welcome to Bio-Link |
|
Bio-Link is a strategic consulting and biotechnology business development company that works with Australian and international life sciences companies and academic institutions to facilitate deals based on strategic technology analysis and consulting, business development, project management and deal negotiation. Bio-Link also provides technology scouting and representation services for Australian and international companies. Bio-Link has offices in Melbourne and Sydney. Please explore our website to learn more about Bio-Link’s services and client endorsements and our portfolio of client technologies.
|
|
|
